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ITu026IProcalcitonin as a marker of lower urinary tract
infection versus acute pyelonephritis in children
C. Rodrig02, C. Pratl , N. Gali\ M. Mendel, M. Gimenez',J.
Dominguez', V. Ausina'
tServei de Microbiologia; 2Servei tit Pediatna. Hospital Universitari Germans
Trias i Pujol, Badalona, Spain
Objective: To assess the usefulness of Procalcitonin (PCT) serum, concen-
trations measurement in distinguishing between lower urinary Tract infec-
tion (UTI) and acute pyelonephritis in children.
Methods: We studied 50 patients from Pediatric Emergency Department
presenting clinical signs suggesting UTI such as fever and abdominal pain or
irritability, vomiting an leukocyturia at the urineanalisis. A serum sample
was obtained at the lime of admission for white cell count and for
measurement of PCT. Blood and urine cultures were performed, and
were included in the study only those with positive urine culture. Imaging
techniqucs were performed during the acute phase (ecography and cysto-
graphy) to check urinary now obstruction and vesicoureteral reflux, and 5-6
months after the episoclc (gammagraphy) to check the presence of renal
parenchymal damage or scarring. We defined 3 groups among the results
obtained in these explorations: I, lower UTI: absence offever and absence of
rcnallesions in acute and late explorations. 2, febrile UTI without renal scars.
3, febrile UTI with renal scars at late gammagraphy. PCT concentrations
were measured by inmunoluminometric assay (Lumitestr® Brahms Diag-
nostica, Germany) following manufacturer instructions.
Results
White cell MeanCRP MeanPCT
Patients n (countjmm3) (mgjml) (ngjml)
Group 1 15 16171 20.72 (1.50-71) 0.41 (0.17-0.82)
Group 2 25 18528 100.49 (0.50-260.40) 9.67 (0.12-95)
Group 3 10 17660 159.27 (46.90-412) 13.87 (1.05-62.2)
With a PCT level> 1 ng/ml the sensitivity and specificity to discriminate
between group 1 and group 3 are 100% and 100% respectively.
Conclusion: PCT levels at the time Of admission show a significant
correlation (p < 0.0001) with severe renal involvement. Serum PCT
measurement can be useful to prevent scarring by agressive therapy and
follow-up.
P:10/1 - Mycobacterial infections
ITuP1691 Evaluation of the polymerase chain reaction on
peripheral blood mononuclear cells In the diagnosis of
pulmonary tuberculosis
B. Massoud, A. EI Hefuawy, S. Abd EI Salam, A. Darwish, M. Hanafy
Faculty ofMedicine, Alexandria, Egypt
Objective: The current study was undertaken to evaluate detection of
Mycobacterium tuberculosis DNA in peripheral blood mononuclear cells
(PBMCs) by polymerase chain reaction (PCR) as a rapid method for
diagnosis ofactive pulmonary tuberculosis.
Methods: The study included 30 patients recently suspected as having
pulmonary tuberculosis on clinical and radiological basis (group I) and 20
patients with proven pulmonary tuberculosis and receiving antituberculous
drugs, (group II). Sputum specimens were examined for acid fast bacilli and
cultured on Lowenstein-Jensen medium. M. tuberculosis DNA in PMBCs
ofthese patients was amplified using primers specific for the IS6110 insertion
sequence.
Results: Among group I, 19 cases (63.3%), 21 cases (70%) and 25 cases
(83.3%) were positive by microscopy, LJ culture and PCR respectively. Of
5 cases that were negative by PCR, two revealed by culture Mycobacteria
other than M. tuberculosis. Among group II. the 8 cases that were positive by
PCR showed poor clinical and radiological response to treatment while the
12 patients that were PCR negative showed clinical and radiological
improvement.
Conclusion: Detection ofM. tuberculosis DNA in PBMCs is more sensitive
than other methods and as specific as culture from sputum for the diagnosis
of recent pulmonary tuberculosis This is in contrast to our previous
experience with PCR on bronchoalveolar lavage where we got high
percentage of false positive results that were attributed to residual DNA in
bronchoscopes. The method many be of value also in monitoring response
to antituberculous drugs.
[TUiiV0] Application and evaluation of PCR for the diagnosis
of tuberculous meningitis
A. Rafi'. J. L. Stanford2
ITabriz University ofMedical Sciences, Tabriz, Iran; 2UCL Medital School,
London, United Kingdom
In view of the importance of early diagnosis of tuberculous meningitis
(TBM), the efficiency of the polymerase chain reaction (PCR), one of the
most reliable and sensitive DNA-based assays, was compared with conven-
tional methods (acid-fast microscopy and culture) for the detection of M.
tuberculosis in cerebrospinal fluid (CSF) specimens from patients suspected of
TBM.
Of the 29 CSF specimens from highly probable TBM patients (based on
clinical features), 25 were positive by PCR (86.2%), whereas only one out of
29 was acid-fast microscopy (AFM) positive (3.4%), and 5 out of29 were
culture positive (17.2%). No positive results were found by AFM, culture or
PCR in the non-tuberculous control group. The rcsults ofthis study indicate
that application of PCR should be extremely useful for the diagnosis of
TBM.
ITuP171I DetectIon of mycobacteria In MB/BacTsystem from
extrapulmonary specimens
O. Dorobat, T. Biolan, EM. Ceausu, M. Burtea
Clin. Microbiol. Lab., Clin. Hospital of Infectious Diseases Dr. V. Babes,
Bucharest, Romania
ObjectIves: To evaluate the MB/BacT system for the detection of myco-
bacteria from extrapulmonary specimens in comparison with egg media,
our routine isolation method.
Methods: A total of 523 clinical samples (455 pleural fluid. 45 CSF from
non-HIV and 23 from HIV patients) have been tested in MBfBacT system
and with egg media. Incubation time was 42 days for MB/BacT system and
60 days for the egg media.
Results: Overall 150 (28.6%) mycobacteria were isolated. In MB/BacT
system 140 (26.7%) could be recovered and only 76 (14.5%) with routine
media. MB/BacT alone detected mycobacteria from 74 (14.1 'Yo) specimens
and egg media alone from 10 (1.9%) specimens. Of523 specimens tested 32
(6.1 %) were microscopically positive for acid-fast bacilli and 21 could be
confirmed by culture. The mean time to detection isolates by MB/BacT
system was 19.8 (5.5-38.5) days and for egg media 37.9 (25-60) days. The
mean time for pleural fluid was 20.9 days, for CSF from Don-HIV patients
was 18.1 days and for CSF from HIV patients 16.5 days in MB/BacTsystem.
Conclusions: Recovery rates of mycobacteria in MBfBacT system was
significantly higher then those in the solid media. The mean time to
detection of mycobacteria was considerably shorter in MBfBacT system.
A combination of solid and liquid media is optimum for recovery of
mycobacteria from extrapulmonary specimens.
ITuP1721 Rapid diagnosis of genitourinary tuberculosis by
polymerase chain reaction and non-radioactive DNA
hybridization
O. Moussa', 1. Erakyl, M. EI_Far2, H. Osman2, M. Ghoneim'
tUrology and Nephrology Center; 2Faculty ofScience, Mansoura University.
Mansoura, Egypt
ObjectIve: To establish a PCR assay for the rapid detection and identifica-
tion ofMycobacteria in urine, and to assess the value ofsuch assay in routine
laboratory diagnosis of genitourinary tuberculosis.
Materials lind methods: A total of 1000 urine specimens from patients with
clinical suspicion ofurinary tuberculosis were examined. Two assays for the
detection and identification of Mycobacterium tuberculosis (M. tuberculosis)
complex and Mycobacteria other than tuberculosis (MOTT) by non-radio-
active DNA hybridization of PCR-product were applied. The first assay
used PCR primers and probe derived from M. tuberculosis species-specific
DNA insertion sequence 1S6110 and the second utilized mycobacterium
genus-specific sequence encoding ribosomal ribonucleic acid (168 rRNA).
The results obtained by PCR were compared with those obtained by
standard microbiological methods; [acid-fast bacilli (AFB) stain and culture
on liquid and solid media].
Results: Compared with cultures, the sensitivity of AFB staining was
(52.07%) and the specificity was (96.7%). In comparison with the results
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of culture, the overall sensitivity and specificity were 95.59%, 98.12% for
IS6110-PCR; and 87.05%, 98.9%, for 16S rRNA gene-PCR, respectively.
Conclusion: The high sensitivity and specificity in addition to the potential
for rapid detection ofMycobacteria, makes this test a useful tool in the clinical
management of mycobacterial infection in urine. Urine specimens may
contain M. tuberculosis and/or other Mycobacteria, therefore; there is an
advantage to using genus-specific primers in parallel with species-specific
primers in the PCR assay.
ITuP1731 Misidentification of rapidly growing mycobacteria in
the API Coryne system
S. Brunner. G. Pfyffer. A. von Graevenitz
Department ofMedical Microbiology, University ofZurich, Zurich,
Switzerland
objectives: Rapidly growing mycobacteria (RGs) may be misdiagnosed in
the clinical laboratory due to their Gram-positivity, growth on blood agar
and macroscopic and microscopic morphologies (von Graevenitz and
PUnter-Streit, Eur.). Epidemio!. 14: 519-20. 1998). We wanted to deter-
mine the reactions ofRGs in a commercial system for coryneforms (whose
database does not contain them) in order to detect codes that may point to
their presence.
Methods: Clinical strains of Mycobacteriumfortuitum (23), M. abscessus (21),
and M. che/onae (16), diagnosed by traditional mycobacterial reactions
(including nitrate reduction [Virtanen) and urease [Wayne) from 1-wk
old Loewenstein-Jensen slants, were inoculated into API Coryne (V. 2.0)
galleries (bioMerieux, France), incubated 24 h at 37°C, and coded according
to instructions. Besides, reactions in Nitrate Broth and Urease Broth (both
Difco) were checked following incubation at 2, 24, and 48 h.
Results: API Coryne generated codes corresponding to otber nonfennen-
tative Gram-positive rods: Rhodococcus spp. (first choice in 45 strains; T
values 0.50-1.00), Corynebacterium propinquum (13; 0.83-1.00), Arthrobacter
spp. (2; 0.91-0.98), and Brevibacterium sp. (1; 0.72). Discrepant results for
urease (Christensen and Wayne +, API-) were 4, and for nitrate
(Virtanen-, Nitrate Broth and API +),6.
Conclusions: The above diagnoses in the API Coryne system are at least
suspicious ofRGs and would call for further confirmatory tests.
!TuP1741 Analytic performance of the BDProbeTee8 ET system
for the dIrect detection of MycoblIr:terlum tuberculosis complex
T. Brink, D. Copertino, G. Franklin,). Harris, O. L1orin, K. Willliams,
D. Wolfe,). Wood, K. Vanson
BD Biosciences, Sparks, MD, United States
Objectives: A nucleic acid amplification test (DTB) has been developed for
the direct detection of Mycobacterium tuberculosis complex (M.tb) on the
BDProbeTec@ ET System. The effects of interfering substances, assay
specificity, and sensitivity of the DTB assay have been evaluated. The risk
of DNA contamination during an assay run was investigated in earry-over
and eross-contamination studies.
Method: To examine the effect of interfering substances in human respira-
tory samples, various substances, including blood, were added to M.tb
positive and negative NALC/NaOH sediments and assayed. Potential cross-
reactants were tested by assaying processed samples containing cells or DNA
from non-M.tb microorganisms (n = 121). Analytical sensitivity of the
assay was determined by testing serial dilutions of31 M.tb complex isolates.
Instrument related carryover was evaluated by assaying positive and
negative controls in alternating runs. To evaluate cross-contamination
within a run, positive and negative controls were alternated and tested.
Results: No substance tested was found to have an effect on the detection of
M.tb or the internal amplification contro!' The assay did not cross-react with
any of the microorganisms tested and detected 31/31 M.tb complex organ-
isms with an overall limit ofdetection oft 25 cfu/mL. A false positive rate of
0.0% (0/950) and 0.21 % (2/960) was seen in the carry-over and cross
contamination studies. respectively.
Conclusion: The assay developed for the direct detection of M.tb complex
and the BDProbeTec8 ET System provide a sensitive and specific method
for the detection of M.tb complex and did not demonstrate inhibition by
various substances, including blood. The carry-over and cross-contamina-
tion studies support the conclusion that the BDProbeTec8 ET System
provides a dosed system for amplification and detection.
ITuP17S! Evaluation of the BDProbeT~ ET Mycobacterium
tuberculosis complex (DTB) direct detection assay for use with
clinical respiratory specimens
L. H. Blumberg, C. Constantinou. A. von Gottberg
Mycobaeteriology Laboratory, South African Institutefor Medical Research and
the University of the Witwatersrand,Johannesburg, South Africa
Background: Rapid diagnosis of tuberculosis (TB) impacts positively on
patient management and disease control, especially in our high TB pre-
valence area (400 cases/loo,OOO population). New DNA amplification
techniques provide an advantage over culture methods. The BDProbeTec
ET System is an automated DNA amplification system which utilizes
homogenous Strand Displacement Amplification (SDA) and fluorescent
energy transfer detection. An Internal Amplification Control (lAC) is run
with each sample to monitor for specimen inhibition and to verify the SDA
reaction.
ObjllCtlve: To evaluate the performance of the BDProbeTec ET System
DTB assay for the detection ofMycobacterium tuberculosis complex.
Method: Respiratory specimens from untreated patients suspected of TB
were submitted to the diagnostic TB laboratory. The DTB assay results were
compared to microscopy and culture results from both solid and liquid
media, with species identification by in-house PCR or biochemical testing.
Discrepant results were resolved by reviewing the patient's clinical record.
Results: Of the 941 pulmonary specimens tested, 407 were positive for
myeobacteria ofwhich 317 were TB. Initial overall sensitivity and specificity
ofthe BDProbeTec ET DTB assay were 90.8% and 98.2%, respectively. For
smear positive specimens the sensitivity and specificity of the DTB assay
were 99% and 90%. For smear negative specimens the sensitivity and
specificity were 74.5% and 98.5%. After review of patient records. 2 of
the 11 DTB false positive results were found to be true positives, resulting in
a final overall sensitivity and specificity of9O.9% and 98.6%.
ConclusIon: These data suggest that the BDProbeTec ET System is a
sensitive method for the detection ofTB, with excellent specificity.
ITuP1761 Comparison of Etest with a genotypic method for
detection of darithromydn resistance in Mycobacterium avium-
intracellu/are
A. Wanger, B. Boulet
University of Texas Medical School, Houston, Texas, United States
Mycobacterium avium-intracellulare (MAl) is a significant pathogen in immu-
nocompromised patients. Although, prophylaxis with clarithromycin (CH)
is recommended to prevent dissemination, resistance develops with pro-
longed use and CH plus ethambutol (EB) is used for therapy. Susceptibility
testing of MAl to CH is recommended for patients previously treated yet
subsequently grow MAl from a sterile body site. No standardized method is
currently available. We previously demonstrated correlation of Etest with
agar dilution and Bactec for susceptibility testing of MAl to CH. The
accuracy of Etest MICs was further evaluated by comparing the CH MICs
for 24 blood isolates of MAl with the presence of specific mutations in the
23S rRNA region known to be associated with CH resistance. DNA
sequencing of a PCR product amplified from the peptidyltransferase
region of 23S rRNA was used. Etest was performed using a McFarland
3.0. Mueller Hinton agar with 5% blood, 10% OADC, ambient incubation
at 35°C for 4-7 days. MICs ofCH ranged from 0.032-~256lJg/ml.Six of
the 24 isolates with MICs of~256 JJg/ml (resistant = MlC ~ 321Jg/m1) had
A-C or A-G mutations at base pair 2568 or 2569. Eighteen isolates with
MICs of 0.032-16 JJg/ml had no mutations. MAl ATCC 35713 strain
susceptible to CH, MIC of 0.047 JJg/ml, had no mutation present. Combi-
nation testing was also performed using CH and EB Etest strips with the
resistant isolates (MIC CH and EB > 256) and synergy was demonstrated.
Etest is an accurate method for phenotypic detection of CH resistance in
MAl confirmed by genotypic methods.
ITuP177! Direct diagnosis of tuberculous pleural euslon by
two nudeic acid amplification methods
o. Dorneanut, H. Ries2, K. Pe1z2, D. Diculencu1, D. Buiuc'
I University ofMedicine and Pharmacy, lasi, Romania; 2Institutfilr
Medizinische Mikrobiologie und Hygiene. Freiburg. Germany
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Conduslons: sPCR is more accurate, but less rapid than LCR in the
diagnosis of tuberculous pleural effusion; sPCR can detect all mycobacteria,
precisely identified by sequence analysis of the amplified nucleic acid.
Objectives: To assess and compare the efficiency of two nucleic acid
amplification methods in the direct diagnosis of tuberculous pleural effusion.
Methods: We have investigated 81 pleural fluid specimens collected from
patients suspected for tuberculous pleural effusion, by growth of mycobac-
teria on Lowenstein-Jensen slants and in MB/BacT system (Organon
Teknika) and by two nucleic acid amplification methods: *an in-house
semi-nested polymerase chain reaction (sPCR) based on 16S rRNA,
followed by sequence analysis of the amplified nucleic acid, and **a ligase
chain reaction (LCR) from the commercial kit LCx M. tuberculosis (Abbott).
Results: Ten specimens resulted into mycobacterial growth on Lowenstein-
jensen slants and/or in MB/BacT system; 19 specimens were positive by
sPCR and 12 by LCR. All the positive specimens contained Mycobacterium
tuberculosis complex. After re-evaluation of the nucleic acid amplification
results according to the clinical diagnosis, the sensitivity (SN), specificity
(SP), positive predictive value (PPV), negative predictive value (NPV) and



















ITuP179! Clinical benefitvs. financial burden of rapid methods
for mycobacterial diagnosis
F. B. Gengler, F. Munisso, F. C. Schneider
lAboratoire National de Sante, Luxembourg, Luxembourg
Objectives: To assess clinical benefit and extra cost of adding MGIT and
LCx to classical microbiology.
Methods: Auramine and Ziehl-Neelsen stains. LCx according to the
manufacturer's notice. Culture media included L-j, Coletsos, 7Htl,
MGlT. For smear + (Sm +) and all specimens from suspected active TB a
radiometric Bactec was added.
Results: Out of 6382 submitted specimens, 232 had a + culture for
Mycobacterium tuberculosis, 259 a + and 732 a - LCx. 60 Lex + specimens
stayed culture -;, 52 in follow-up pts. Among culture + specimens 78%
were Sm +,9.9% Sm-; and LCx +. 12.7% were culture + only. For 211
pulmonary specimens, the figures were 79.2%, 8.5% and 12.3%. for 21
extra-pulmonary specimens 66.7%, 23.8% and 9.5% respectively. 161
specimens could be evaluated for all 3 culture systems: 157 wete + for the
slant tubes, 145 for Bactec and 151 for MGIT. The median duration to
reactivity was 11 d (4 to 40) for MGIT, 12 d (2 to 39) for Bactec and 21 d (6 to
60) for agar-slants. Apparent time advantage of MGIT was hampered by a
bacterial mass too small for rapid identification or resistance testing. The
reagent cost for LCx was S12.5/test. The cost ofpotential time gain in Sm-;,
LCx + initial specimens amounts to $506 per case. MGIT runs up to $96/ +
culture.
Conclusion: LCx has clinical benefit for primary TB diagnosis but is
unreliable for follow-up. MGIT and Bactec considerably speed up culture
and subsequently resistance data. Both substantially add to cost.
ITuP1781 The comparison of the PeR and culture method for
the diagnosis of pulmonary and extra pulmonary tuberculosis
cases
B. Kocazeybek" V. Koksat2, 6. Giilsoyl, A. Ayyi1diz'
I Florence Nightingale Hospital Dept. ofMicrobiology, Istanbul; 2Bur,
Molecular Diagnosis lAboratory, Istanbul, Turkey
Objective: To compare the PCR refererence method with Lowenstein-
Jensen (LJ) to diagnose tuberculosis in 300 clinical samples which were sent
from different clinics of the relied to Florence Nightingale Hospital in 16
months period.
Materials and Methods: Totally 300 clinical samples consisting of 200
(66.66%) pulmonary tuberculosis (PT) and 100 (33.33%) extrapulmonary
tuberculosis (EPT) which were sere to the Microbiology Laboratory from
the pulmonary disease departments of Florence Nightingale Hospital
between the dates August 1998 and December 1999. The samples were
stained with Ehrlich-Zieh1-Nielsen (EZN) and were examined by direct
Microscopic investigation and then they were decontaminated with NALC
+ 4%NaOH and were cultured in LJ with EZN. In addition to this,
sufficient amount of PCR test was made from each sample. For mycobac-
terium tuberculosis complex, primary pairs from IS 6110 region were used.
Kappa Test was used in the statistical evaluation ofour results.
Results: In 200 cases diagnosed as PT clinically 51 (25.50%) were found
positive with the culture and 55 (27.5%) were found positive with the PCR.
In 100 cases disposed as EPT clinically, 23 (23%) were culture positive and 26
(26%) were positive with the PCR. When the compliance of the PCR and
the LJ which is the reference method for tuberculosis is emphasized, the
compliance of the PCR with LJ in PT cases was found statistically at high
ratio (Kappa 94% > 70%). In EPT cases, when parallel results with LJ and
PCR were taken into consideration, the compliance ratio was found just
below the statistically acceptable ratios. (Kappa 59% < 70%). As we
investigated all the cases, and when the parallel results of PCR and LJ
were taken in to consideration the compliance ratio was found statistically
high (Kappa 84% > 70%).
Conduslon: Our study showed that all tuberculosis cases especially in PT.
the culture positivity and PCR results had a great compliance where as in
EPT the culture positivity and PCR results compliance was found just below
the acceptable ratios. We think that incompatibility was relied to the few
number ofcases ofEPT, the unproper collection ofthe samples according to
the specific anatomic structures for PCR method, or the lack ofvariation of
the primary pairs taken from the different regions of the genome.
ITuP180 I Mycobacterium miaoti infections in Germany
E. Richterl , H. Dalil~ge-Tamm2, G. Gurath3, I. Sobottka4, S. Rlisch-
Gerdesl, S. Niemann
'Nationales Referenzzentrumftir Mykobakterien, Borski; 2Niedersiithsisches
lAndesgesundheitsamt, Hannover; JCemeinschtiftspraxis lAbor Clotten,
Freiburg; 4Universitiitsltrankenhaus Eppendorf, Hamburg, Germany
Objectives: Mycobacterium microti has been described to be isolated from
rodents, so far infection in humans rarely have been verified. This may be
due to the difficult primary isolation and identification ofM. microti because
of its very limited growth. Yct, use of modern molecular methods enables
the detection and identification of this species. In this study we summarise
several cases ofM. microti infections in human clinical and animal specimens
submitted for routine mycobacterial diagnostics.
Methods: Spoligotyping was performed from routine culture media, in
which growth of TB-bacteria was confirmed by AccuProbe assays. Drug
susceptibility was determined using the BACTEC 460TB system.
Results: M. microti could be detected in human and animal specimens. In all
cases primary isolation was hampered by the slow growth of the organism
and conventional biochemical identification was impossible. However.
spoligotyping revealed M. microti types vole and llama both in human as
well as animal specimens. Susceptibility tests were only feasible from the
llama type isolates, resulting in susceptibility to all 5 first line drugs. In
accordance to these results patients improved under regular tuberculosis
treatment.
Conclusions: In this study we present the first cases ofM. microti infections
in Germany confirming the clinical importance for humans. Since primary
isolation is difficult, the occurrence of this species in humans may be
underestimated so far. Thus, infection with M. microti has to be taken
into account e.g. in patients with typical clinical signs oftuberculosis without
bacteriological proof.
!TuP181I Rapid INH resistance detection by PCR in M.
tuberculosis
M. Torres, A. Criado, N. Gonzalez,}. Aznar,j. Palomares
University ofSeville. Seville, Spain
Objetives To evaluate a new rapid method for the detection ofmutations in
the katG gene of isoniazide resistant Mycobacterium tuberculosis clinical
isolates.
Methods: Thirty five strains were studied: 15 susceptible strains and 20
isoniazide (INH) resistant strains with distinct RFLP patterns and two
different SSCP patterns (18 strains had a point mutation at the position
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315 of the katG gene and 2 were uncharacterized). INH susceptible M.
tuberculosis H37Rv was used as control. All the strains were studied by using
a new real time amplification method (LightCyder. Roche Molecular
Biochemicals). The method uses two primers (TB86 and TB87) to amplify
a 209 bp fragment of the katG gene and two short oligonucleotide probes
(TB anchor and TB sensor) that hybridize to an internal sequence of the
amplified fragment during the annealing phase of the PCR cycle. TB sensor
probe is labelcd with Rcd 640 and thc TB anchor with fluorescein. The
probes were designed to detect the most frequent mutation related to INH
resistance. Differences in the melting temperature allows to discriminate
between susceptible and resistant strains. Results can be obtained after 40
minutes.
Results: AllIS INH susceptible strains showed a Tm of73°C, while the Tm
showed by the resistant strains was at least 3.5°C lower. The 18 strains which
had the point mutation at the position 315 ofthe katG gene, showed a Tm of
68.5°C and the 2 uncharaeterized resistant strains showed a Tm of 67SC.
Conclusions: This is a rapid, sensitive and highly specific metod to detect the
most frequent point mutation at the katG gene conferring INH resistance
and could be applied for the detection ofdifferent mutations in this and other
genes in M. tuberculosis INH resistant strains.
ITuP1821 Rapid RIF resistance detection by PCR in M.
tuberculosis
M. Torres, A. Criado, N. Gonzalez,]. Amar,]. Palomares
University ofSeville, Seville, Spain
Objetives: To evaluate a new rapid method for the detection ofmutations in
the rpoB gene of rifampin (RIF) resistant Mycobacterium tuberculosis
clinical isolates.
Methods: Thirty-seven strains were studied: fifteen susceptible strains and
twenty-two RIF resistant strains with distinct RFLP patterns and three
different 55CP patterns (nineteen strains had a 5531 L mutation, one strain
with 5526D at the rpoB gene, and two wild type strains). RIF susceptible M.
tuberculosis H37Rv was used as control.
All the strains were studied by using a new real rime amplification method
(LightCycler. Roche Molecular Biochemicals). The method uses two
primers (TR9 and TRB) to amplify a 157 bp fragment of the rpoB gene
and two short oligonucleotide probes (rpo anchor and rpo sensor) that
hybridize to an internal sequence of the amplified fragment during the
annealing phase of the PCR cycle. TB sensor probe is labeled with Red 640
and the TB anchor with fluorescein. The probes were designed to detect the
two more frequent mutations related to RIF resistance. Differences in the
melting temperature allows to discriminate between susceptible and resistant
strains and the results can be obtained after forty minutes.
Results: All fifteen RIF susceptible strains and the two wild type strains
showed a Tm of64.5 ± 0.2°C, while the Tm showed by the resistant strains
was at least 2.5°C lower. The Tm ofthe strains harboting the 5531L and the
5526 mutations were 67°C and 58.4 °c respectively.
Conclusions: This is a rapid, sensitive and highly specific metod to detect the
two more frequent point mutation at the rpoB gene conferring rifampin
resistance and could be applied for the detection ofdifferent mutations in this
gene in M. tuberculosis strains..
ITuP183! Value of rapid molecular testing In tuberculose
diagnosis
R. Wejbora, W. R. Pohl, G. Hackel, F. Kummer, K. H. Stradal, P. M.
Bayer
Wilhelminen Hospital-Ma 15/Feldgasse, Vienna, Austria
Objectives: 1) To evaluate ifPCR results influence the therapeutic approach
in an early phase and shorten the time-span to start the therapy. 2) To
establish the cost for an invasive diagnostic procedure (Bronchoscopy) and
the need for less medication.
Methods: 446 clinical samples from 107 patients with abnormal chest x-ray
were tested for detection of mycobacterium tuberculosis complex (MTB)
using acid fast bacilli staining (AFB), polymerase chain reaction (PCR Cobas
Amplicore Roche) and Bactec radiometry and Lowenstein-Jensen (L. ].)
culture. The cost for each test, medication and bronchoscopy was estab-
lished. Clinical signs and symptoms, history of exposure, ethnic and risk
factors were given the clinical score in several categories: low probability of
TB-infection 0-2, intermediate 3-4 and high 5 or more SCOIn. Decision to
proceed with any therapy was in protocol with or without knowing PCR
results.
Results: PCR results were helpful for decisions on all patients with 0-2
clinical score and all AFB negative and PCR positive and also the positive
AFB to confirm the MTB-complex.
The cost savings for the low probability group was established at 19378
euro.
Condusion: On the basis ofPCR results, a therapy can be established with
savings in cost.
ITuP1841 Oinlcal evaluation of the Cobas Ampllcor
Mycobacterium tuberculosis test for detection of MTB in
respiratory specimens
S. Levidiotou!, E. Galanakis!, E. Gessoulit, C. Pappa1, D. Papamichadl ,
E. Papanikou1, D. Stefanou2• S. H. ConstantopoulosJ
'Dept of Microbiology; 2Palhology; JPneumonology, University Hospital,
Ioannina, Gruce
We evaluated the PCR Cobas Amplicor MTBtest (Roche Diagnostics) for
the routine detection ofM. tuberculosis (MTB) in respiratory specimens. The
results were compared with those of the conventional Lowenstein-Jensen
medium, MB/BacT liquid culture and the clinical findings. A total of 1.600
respiratory specimens taken from 1.100 patients individuals with possible TB
were examined for the detection of MTB. Among the 110 culture-positive
MTB specimens, 88 were positive with the Cobas Amplicor MTB PCR test
and among the 1.490 culture-negative specimens, 1.474 were Cobas Ampli-
cor MTB negative. After detailed interpretation the overall sensitivity,
specificity, positive and negative predictive values for the Cobas Amplicor
MTB PCR test were respectivelly 74.6%, 99.7%, %% and 97.7%. In
smear-positive specimens, the sensitivity, specificity, positive and negative
predictive values of the Cobas Amplicor MTB test were 87.2%, 98.5%,
78.9% and 99.1 %. The inhibition rate was 2% and ean be detected by the
internal control of the test itself. In conclusion, the automatic Cobas
Amplicor MTB PCR test is a rapid, sensitive, specific and useful tool for
the routine diagnosis of respiratory tuberculosis.
ITuP18S1 Evaluation of recovery and time to detection of
Mycobacterium tuberculosis in the MBlBacTsystem compared
with Lowenstein-Jensen medium
s. Levidiotou. E. Galanakis, E. Gessouli, C. Pappa, E. Themeli, A.
Eleftheriou
Dept. ofMicrobiology, Medical School, University ~ Ioannina, Greece
Objectives: To evaluate the performance of the non-radiometric liquid
culture MB/BacT system (Organon Technika) in comparison to conven-
tional solid Lowenstein-Jensen (LJ.) medium for the detection ofM.T.B. in
clinical specimens.
Materials and Methods: 4660 various clinical specimens (respiratory and
others) were digested and decontaminated to the standard CDC NALC-
NaOH method. After the decontamination procedures each specimen was
inoculated onto two solid LJ. slants and into one MB/BacT botde.
Results: 183 Mycobacterium tuberculosis isolates were recovered. MB/
BacT recovered 179 (97.81%) MTB isolates and L.J. recovered 156
(85.24%). 152 of the MTB isolates (83.cl6%) were recovered with both
systems. MB/BacT system was significantly more sensitive than LJ. (p :S
0.0001).
The detection time of MTB, significantly shorter with MB/BacT than
LJ., in both the smear-positive and negative specimens was 8-15 days and
22-40 days respectively. However the contamination rate was higher in
MB/Bact (8.2%) than in L.]. (3%).
Conclusions: The MB/BacT system is an automated, sensitive and rapid
method for the detection of MTB in clinical specimens.
ITuP1861 Evaluation of the BACTEC MGrT 960 automated
antlmycobacterial PZA susceptibility test
B. Byers, P. S. Beaty, M. Warns
BD Biosciences, Sparks MD, United States
Objective: Pyrazinamide is now considered as the third most important
drug in the treatment of Mycobacterium tuberculosis infection. This study
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evaluates a new fully automated PZA Antimycobacterial Susceptibility test
that has been developed for the BACTEC MGIT 960 Mycobacteria growth
and detection system.
Methods: The BACTEC MGIT 960 system is an automated growth and
detection system using an oxygen sensitive f1uotescent indicator to monitor
microbial respiration. An Antimycobacterial Susceptibility Test using a
PZA containing MGIT 960 tube compared to a growth control was
evaluated. The test system includes a MGIT 960 PZA test medium, a PZA
supplement and PZA drug. The test medium is MGIT broth with the pH
reduced to 5.8-5.9. The supplement is a modified Middlebrook OADC
supplement containing polyoxyethylene stearate (POES). The PZA is tested
at a concentration of 100 microgram/mI. The system was compared to the
BACTEC 460TBTM System. Twenty strains ofM. tuberculosis were used.
Ten strains that were sensitive and ten strains that were resistant by the
BACTEC 460TB system were tested. Tests were performed in triplicate
with multiple lots ofBACTEC MGIT %0 PZA reagents.
Results: The BACTEC MGIT 960 results were equivalent to the BACTEC
460TB results. The average time in protocol for a MGIT 960 PZA test was
6.5 days. The PZA MIC on the BACTEC MGIT 960 of rwenty sensitive
strains was within one dilution of the BACTEC 460 MIC. The BACTEC
MGIT 960 PZA AST system is an accurate and reproducible method.
!TuP1871 Evaluation of the BACTEC MGIT960 automated AST
procedures for SIRE and PZA
P. S. Beaty, B. Byers, M. Warns, P. Warns
BD Biosciences, Sparks MD, United States
Objective: To evaluate the procedures and reagents for the new BACTEC
MGIT 960 Antimycobacterial Susceptibility test system.
Method: An Antimycobacterial Susceptibility test using a panel of drug
containing MGIT 960 tubes compared to a growth control was evaluated.
The test procedure includes the drugs (microgram/mI): streptomycin (1.0
and 4.0), isoniazid (0.1 and 0.4), rifampin (1.0), ethambutol (5.0 and 7.5) and
pyrazinamide (100). Pyrazinamide requires media, reagents and procedures
designed specifically for this test. Thirty strains of Mycobacterium tubercu-
losis with varying susceptibility patterns were used. Tests were performed in
triplicate with multiple lots of BACTEC MGIT 960 reagents. The system
was compared to either the modified Method of Proportion (MOP) for
SIRE or the BACTEC 460TB system for PZA. The low concentrations of
streptomycin, isoniazid and ethambutol. which correlate to the critical
concentration of the MOP method, were tested first. Strains determined
to be resistant were then tested at the high drug concentration for each of
these drugs. The BACTEC MGIT 960 results were equivalent to the
comparison method. Any observed disagreements occurred in strains that
showed evidence of partial resistance at the low-drug concentration on the
BACTEC 960 system.
Results: The BACTEC MGIT 960 AST system is an accurate and repro-
ducible method. The average time in protocol was 6.5 days. The test can be
performed directly from positive MGIT growth and detection tubes or
visible growth from solid medium. The inclusion of rwo drug concentra-
tions allows a greater degree offlexibility in accurately characterizing drug
susceptibility patterns, particularly with MDR strains.
ITuP1881 An evaluation of the BACTE(® 9000MB (Becton
Dickinson)
S. A. Livseyl, M. Stevens', E. G. Smith2, T. Turner2, R. AIlen2, S.
Gardiner2
tMedical Devices Agency, Leicester; 2Regional Mycobacterial Unit,
Birmingham, United Kingdom
Objectives: To determine the performance of the BACTEC® 9000MB by
comparison with the MB/BacT (Organon Teknika) and conventional solid
media (modified Lowenstein-Jensen).
Methods: A total of 1067 samples (59% sputum) were tested from patients
with suspected tuberculosis. Sputum digestion and decontamination was by
the 15 minute NALC - NaOH method at a final concentration of2%.
Results: Acid-fast bacilli were detected and seen in 131 samples from at least
one of the systems. Acid fast bacilli were detected and seen in 121 (92%) of
the BACTEC® 9000MB bottles, 113 (86%) of the MB/BacT bottles and in
105 (80%) solid media botttles. Ofthe 131 mycobacteria, 95 were confirmed
as Mycobacterium tuberculosis.
The mean detection intervals for all mycobacteria for each system were
BACTEC® 9000MB 11.5 days, MB/BacT 12.8 clays and solid media 22
days. The contamination rates were BACTEC® 9000MB 4.8%, MB/BacT
10.4% and solid media 3.6%.
Conclusions: The specimens in this evaluation were all treated by the same
digestion/decontamination method. However, no single method is ideal for
all culture systems. In particular the method used here was not recom-
mended for both of the automated systems and this may explain why the
MB/BacT performed less well than in a previous Medical Devices Agency
evaluation.
The BACTEC® 9000MB had a higher detection rate to that of the MB/
BacT and had a lower contamination rate. Both automated systems detected
mycobacteria quicker than solid media.
ITuP1891 Rapid detection and identifICation of several
mycobacterial species using PeR·Reverse hybridization assay
E. Padilla,J. M. Manterola,J. Lonca,J. Dominguez, N. Gall, V.
Gonzalcz, V. Ausina
Servicio de Microbiolog{a, Hospital Universitario Germans Trias i Pujol,
Badalona, Barcelona, Spain
Objectives: To evaluate a PCR based technique combined with a reverse
hybridization line probe assay (LiPAS MYCOBACTERIA, Innogenetics,
Belgium) for a rapid identification of several mycobacterial species directly
from mycobacterial liquid cultures.
Methods: The test was evaluated on 98 mycobacterial strains from different
origins (17 reference strains, 81 strains isolated from clinical specimens), 3
mycobacterial mixed cultures (M. xenopi + M. avium, M. terrae + M.
avium, and M. kansasii + M. intracellulare) and 3 strains of bacteria
philogenetically related with Mycobacterium spp. (2 Nocardia spp. and 1
Tsukamurella spp.).
All strains were inoculated into MB/BacT (Organon Teknika, USA).
DNA extracted from positive liquid cultures containing mycobacterial
isolates were first amplified by a PCR technique using biotinylated primers
designed to amplify the 16S-23S rRNA spacer region ofmycobacteria. This
amplified DNA target was subsequently hybridized with specific oligonu-
cleotide probes immobilized as parallel lines on a membrane strip (LiPA).
The LiPA test allows to identify 8 of the most clinically significant
mycobacterial species: M. tuberculosis complex, M. kansasii, M. xerwpi, M.
gordonae, M. avium, M. intracellulare, M. scrt?fUlaceum, and M. chelonae.
Results: The assay correctly identified 74 of 75 mycobacterial strains
included in the study. The test was also able to detect the presence of 2 of
the 3 mixed mycobacterial cultures. We obtained negative hybridization
results for all the 23 mycobacterial strains not included in the strip. Negative
hybridization results were also obtained for 2 strains ofNocardia spp. and I of
Tsukamurella spp. The sensitivity and specificity of the assay applied on MB/
BacT positive cultures were 99 and 100%, respectively.
Conclusions: The LiPA@ MYCOBACTERIA has been shown to be a
rapid, sensitive, and specific test to detect and identify several mycobacterial
species directly from primary liquid cultures.
ITuP190IM. tuberculosis directly identified in sputum by HPLC
M. A. Sempere Alcocer, M. Munoz Delgado, 1. Moreno Arastio
Hospital Costa del Sol, Marbella, Spain
Mycolic acid analysis by high-performance liquid chromatography coupled
with a fluorescence detector (HPLC-FL) improve the sensitivity in the
identification ofmycobacteria and may identify mycobacteria directly from
clinical samples.
Objectives: The objective of our study was to evaluate the HPLC-FL
method directly from smear-positive sputum specimens which subsequently
turned to be a positive culture for M. tuberculosis complex.
Methods: Overall, 27 positive sputum specimens (11 +, 7 + +. and
9 + + +) from 14 patients tested in our laboratory for the isolation and
identification ofacid-fast bacilli (AFB) were included in this study. Mycolic
acid analysis by HPLC-FL was performed from an aliquota of the digested
sputum. Then saponification and convertion to 4-bromomethyl-6,7-
dimethoxycoumarin derivatives, mycolic acid were separated and detected
by HPLC-F1.
Results: For the 27 specimens, we obtained a global sensitivity of44.4% (12
out of27 specimens). When we further analysed the results accordingly to
different classes of specimens, we identified M. tuberculosis by HPLC-FL
with a sensitivity of27.3% (3 out of II) in group + and 28.6% (2 out of7) in
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group 2 +. However in group 3 +, we obtained a sensitivity of77.7% (7 out
of9).
Conclusions: Although mycolic acid analysis by HPLC-FL achieves a
moderate sensitivity for the identification of M. tuberculosis directly from
specimens belonging to groups + and 2 + , for laboratories that use HPLC as
routine method of mycobacteria identification, it would permit a reliable
identification of the tubercle bacilli within 24 h of specimen receipt in
spntum with large AFB (group 3+).
(This work was supported by grant FIS 97/0584 and by Foundation Rey
Fahd Bin Abdulaziz grant AVA 9800/01).
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ITUP19j] Evaluation of a new Oxoid Dryspot kit for the
detection of Streptococcus pneumoniae from blood cultures
A. C. Parker, O. M. Sidnell, T. D. Hartman
Oxoid Ltd, Basingstoke, Hampshire, United Kingdom
Objectives: To evaluate a new fast and simple latex agglutination test for the
detection of Streptococcus pneumoniae from blood cultures.
Methods: The Oxoid Dryspot Pneumo kit consists of latex particles
(sensitised with specific antibody and dried onto cards) which agglutinate
with all the recognised serological types of S. pneumoniae to form visible
clumps. 37 known serotypes ofS. pneumoniae and 35 non-So pneumoniae were
grown in three blood culture systems and tested with the Oxoid Dryspot kit
and two competitor kits.
Results
Dryspot WeUcogen Slidex
Kit (Oxoid Ltd) (Abbot) (bioMerieux)
Blood culture Signal (Oxoid Ltd)
°/0 sensitivity 97.3 94.6 94.6
% specificity 96.8 93.5 93.5
Blood culture BACTEC (Becton
Dickinson)
% sensitivity 100.0 97.3 97.3
% specificity 93.5 90.3 93.5
Blood culture BacTAlert (Organon
Teltnika)
% sensitivity 97.3 94.6 94.6
% specificity 96.8 96.8 96.8
Conclusions: The new Dryspot Pneumo kit is comparable to or better than
Wellcogen and Slidex kits with excellent sensitivity and specificity to strains
grown in different blood culture systems. The Dryspot kit has the advantage
of room temperature storage for 2 years.
ITuP1921 Evaluation of the updated Oxoid Staphytect Plus
and Dryspot Staphytect Plus kits for the dierentiatlon of
Staphylococd from culture media
T. D. Hartman,]. M. Cloke
Oxoid Ltd, Basingstoke, Hampshire, United Kingdom
ObjectIves: To determine sensitivity and specificity of the updated Staphy-
tect Plus and Dryspot Staphytect Plus kits with Staphylococci isolated from
5 culture media.
Methods: Staphytect Plus and Dryspot Staphytect Plus use latex particles
coated with porcine fibrinogen and rabbit IgG, including specific antibodies
to capsular polysaccharides of Staphylococcus aureus.
104 Staphylococci (52 Coagulase Negative, 33 MRSA and 19 Coagulase
Positive) were cultured on Columbia Agar + 5% Horse Blood, Columbia
Agar + 5% Sheep Blood,lso-Sensitest Agar, Mannitol Salt Agar and Baird-
Parker Agar + Egg Yolk Tellurite.
Cultures were tested with Oxoid Staphytect Plus kits and Pastorex Staph-
Plus kit (Sanofi Pasteur) according to manufacturers instructions.
Results: Percentage Sensitivity (Sen) and Specificity (Sp) for each media
Callbors< Col/sheep ISA MSA B-P
Kit Sen Sp Sen Sp Sen Sp Sen Sp Sen Sp
SP 98 96 100 96 100 98 100 98 100 98
DSP 98 96 100 96 100 98 100 98 100 98
PSP98 94 100 92 82 100 100 100 100 96
SP-Sraphytect Plus, DSP-Dryspot Staphytect Plus. PSP-Pastorex Staph-Plus
Conduslons: Staphytect Plus and Dryspot Staphytect Plus produced excel-
lent sensitivity and specificity results with all media tested. Overall, both
products were equivalent to, or better than, Pastorex Staph-Plus.
[TuP1931 Oinical evaluation of a novel medium for saeenlng
for methicillin resistant Staphylococcus aureus (MRSA) directly
from swab samples
L. Sheldon·, I. Hartl, A. Pau112
tOxoid Ltd., Wade Road, Basingstoke; 2Public Health Laboratory, Heath
Hospital, Cardiff, United Kingdom
Objectives: Oxacillin Screen Agar (ORSAB) and conventional media
based on Mannitol Salt Agar were compared for efficiency and ease of use
in isolation of MRSA.
Methods: A total of300 swab samples taken from patients in Geriatric and
High Dependency Units was screened for carriage ofMRSA using ORSAB
with oxacillin at 2 mg/l and Mannitol Salt Agar with oxacillin at 2 and 4 mg/
I. Plates were examined after 24 and 48 hours incubation and colonies typical
in appearance for MRSA selected. Colonies were confirmed as MRSA by a
positive tube coagulase test and oxacillin MIC > 2 mgfl (BSAC recom-
mended breakpoint).
Results: MRSA were isolated from a total of 113 swabs on one or more
media, with 12 swabs growing 2 morphologically distinct colonies on
individual agars. Ninety five swabs were positive for MRSA on ORSAB,
10 swabs grew 2 different colony forms. Mannitol Salt Agar with 2 and 4 mg
ofoxacillin isolated MRSA from 95 and 94 swabs respectively, with 4 and 2
swabs showing 2 morphologically distinct colonies. Overall, the sensitivity
ofORSAB was 84% with a specificity of88%.
Condusions: Use of aniline blue as an indicator for mannitol fermentation
giving an intense blue colour to MRSA colonies on ORSAB after 24 houn
incubation enables colonies to be more easily identified in mixed culture than
the pale yellow colonies seen with Mannitol Salt Agar based media.
Polymixin B incorporated into ORSAB aided selectivity.
ITuP194! Evaluation of a 3 disc method for determination of
MICs for StnrptocomIs pneumoniae
M. V. Boost, M. M. O'Donoghue
Hong Kong Polytechnic Uni"., Hong Kong, SAR, China
Objectives: The study aimed to evaluate the 3 disc diffusion method in
comparison to the SAD and E-test methods in terms of accuracy, costs and
time required for availability of MIC result.
Methods: 213 isolates of S. pneumoniae were screened for penicillin resis-
tance and the MlC determined for those with a zone diameter::; 19 mm
using E-test. MlC was performed using SAD and the 3 disc diffusion
method. Correlation coefficients were calculated for MIC (SAD) venus
sums of zone diameters and for mean MIC (mean SAD and E-test) versus
sums of zone diameters. Results obtained by E-test and the disc ditfusion
method were also correlated. NCCLS interpretive criteria for sensitivity
categories for penicillin were used to determine discrepancy rates..
Results: The correlation coefficient of the 3 disc method against both SAD
and mean MIC was 0.98 and 0.96 against E-test. Essential agreement
between the 3 disc method against SAD was 99.5, against mean MIC, 100,
and against E-test 100. Exact agreement was obtained for 67% of strains
performed by 3 disc procedure in comparison to SAD. The discrepancy rate
was low (7.0% minor errors). all of these being a change in category from
intermediate to resistant. There were no major or very major errors.
Condusions: The 3 disc method offers an accurate method of MIC deter-
mination. The cost is considerably lower than the E-test and the method is
simple to perform, saving one day in the determination ofMIC compared to
combined use of oxacillin disc screen and E-te5t.
